HEL •
Healthcare •
Biotechnology •
Quote as of 08/25/2026 17:52
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeHEL
Market Capitalization81.9 mln
Float24.60 mln
Earnings Date11/11/2026
Piotroski F-Score
4
/ 9
Borderline
Beneish M-Score
-1.62
Likely manipulated
Relative Strength
7
/ 100
Severely lagging
Debt / Equity
0.18
Very low leverage
ROE
-32.31
Deeply negative
Dividend Yield
0.00%
No dividend
Business Description
Nanoform Finland Oyj helps pharmaceutical and biotech companies improve how drugs are made by breaking drug particles down to the nanoscale level. Founded in 2008 and based in Helsinki, the company offers a range of services including specialized particle engineering technologies, formulation development, and analytical support. It also provides STARMAP, a digital tool that helps clients identify which drug molecules are best suited for its nanoforming process.
